Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
PSPro Enables Spatial Proteome Profiling at Single-Cell Type
2026-07-07
The PSPro method, as reported by Mao et al., introduces a proximity labeling-based approach for spatial proteomics, achieving single-cell-type resolution in complex tissue slices. By optimizing antibody-guided biotinylation and affinity purification, PSPro reveals spatial heterogeneity across multiple cell types, providing a substantial advance for tissue-based molecular profiling.
-
I-BET-762: BET Inhibitor Protocols for Ferroptosis and Infla
2026-07-07
I-BET-762, a selective BET inhibitor, empowers precise control of ferroptosis and inflammatory gene regulation in diverse preclinical models. This guide translates the latest mechanistic findings into actionable workflows and troubleshooting strategies, highlighting APExBIO's compound as an essential tool for cutting-edge epigenetic and cancer research.
-
D-Lin-MC3-DMA: Ionizable Cationic Liposome for RNA Delivery
2026-07-06
D-Lin-MC3-DMA is a benchmark ionizable cationic liposome lipid for siRNA and mRNA delivery. It enables endosomal escape, with documented 1000-fold higher potency for hepatic gene silencing versus predecessors. Its role in advanced lipid nanoparticle (LNP) design is essential for therapeutic and research workflows.
-
Strategic c-Myc-Max Inhibition: From Mechanism to Translatio
2026-07-06
This thought-leadership article delivers a mechanistic and strategic roadmap for translational researchers seeking to leverage c-Myc-Max dimerization inhibition—focusing on 10058-F4—as both an investigative and workflow-optimizing tool in oncology and stem cell research. Integrating recent advances in telomerase regulation, DNA repair, and apoptosis, the article contextualizes 10058-F4’s unique value proposition versus conventional inhibitors, providing actionable protocol guidance, competitive insights, and an evidence-driven outlook for the next generation of translational studies.
-
Vernakalant Hydrochloride: Precision Ion Channel Blockade in
2026-07-05
Explore Vernakalant Hydrochloride’s atrial-selective ion channel mechanism, clinical protocol design, and translational assay implications. This in-depth analysis highlights unique PK/PD insights and practical guidance for advanced atrial fibrillation research.
-
Thioguanine Sensitivity in Childhood Relapsed ALL: Drug Resi
2026-07-04
This study systematically profiled in vitro drug resistance in childhood relapsed acute lymphoblastic leukaemia (ALL), revealing that T-cell ALL exhibits increased sensitivity to thiopurines, including thioguanine, compared to B-cell precursor ALL. These findings highlight the potential for more tailored therapy strategies using thioguanine in relapsed T-cell ALL, while also underscoring the need for further translational research to explain the clinical outcome gap.
-
Mitoxantrone HCl: DNA Topoisomerase II Inhibitor in Research
2026-07-03
Mitoxantrone HCl stands out as a DNA topoisomerase II inhibitor with proven value in apoptosis induction, cancer cell viability assays, and novel nuclear receptor targeting. This article delivers stepwise protocols, troubleshooting, and the latest allosteric mechanism insights to help researchers maximize experimental impact.
-
TRIM21 Drives Proliferation and Drug Resistance in Pituitary
2026-07-03
The referenced study uncovers TRIM21 as a critical oncogenic factor in pituitary adenomas, mediating ERK1/2 ubiquitination and phosphorylation to enhance cell proliferation and drug resistance. By identifying TRIM21 as a druggable target, the work highlights the therapeutic potential of epigenetic modulators, such as Quisinostat, in overcoming resistance mechanisms.
-
Clasto-Lactacystin β-lactone: Decoding Proteasome Control in
2026-07-02
Explore how Clasto-Lactacystin β-lactone, a potent proteasome inhibitor, enables advanced research into viral immune evasion and cell death pathways. This article uncovers unique experimental and mechanistic insights for next-generation ubiquitin-proteasome pathway studies.
-
Unraveling the Complete Biosynthetic Pathway of Nicotine
2026-07-02
Chang et al. (2026) provide the first full elucidation of the enzymatic and transport mechanisms underlying nicotine biosynthesis in tobacco. Their findings reveal a vacuolar five-component metabolon coordinating glycosylation, stereoselective condensation, and transport, offering new tools and targets for metabolic engineering and pest resistance in plants.
-
Phenothiazines Enhance Macrophage Antibacterial Function via
2026-07-01
This study demonstrates that phenothiazines significantly boost the antibacterial activity of macrophages by promoting reactive oxygen species (ROS) production and autophagy, offering a host-directed strategy against intracellular pathogens. These findings strengthen the mechanistic rationale for using promethazine hydrochloride in inflammation and immunity research, particularly where conventional antibiotics fall short.
-
Rifampin for Bacterial Resistance Research: Applied Workflow
2026-07-01
Rifampin is a gold-standard rifamycin antibiotic enabling precision transcription inhibition for dissecting bacterial resistance mechanisms. This article details optimized experimental workflows, practical troubleshooting, and cross-domain insights, empowering researchers to leverage APExBIO’s Rifampin for robust, reproducible results in advanced microbiology and synthetic biology studies.
-
AAL-993: Precision VEGF Receptor Inhibitor for Tumor Angioge
2026-06-30
AAL-993 offers robust, target-specific inhibition of VEGFR-1, -2, and -3, making it a top choice for preclinical angiogenesis and tumor metastasis studies. Its high selectivity, reproducible performance, and workflow versatility enable researchers to dissect and modulate angiogenic pathways with confidence.
-
Acridine Orange hydrochloride: Technical Guide for Nucleic A
2026-06-30
Acridine Orange hydrochloride enables reliable, dual-fluorescent nucleic acid staining for cytochemical workflows requiring discrimination of DNA and RNA in situ. This product is recommended for applications such as cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining but is not suitable for protocols needing non-permeant dyes or long-term storage of dye solutions.
-
ARCA Cy3 EGFP mRNA (5-moUTP): Precision Tools for Functional
2026-06-29
Explore how ARCA Cy3 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, enables quantitative, immune-silent mRNA transfection in mammalian cells. This in-depth article uniquely analyzes the interplay of mRNA chemistry, delivery vehicles, and assay reproducibility, offering guidance for advanced functional genomics workflows.